Hodgkin Lymphoma News

• 'First Signal' of Reduced Toxicity From Childhood Cancer Tx Attempts to minimize long-term toxicity from the treatment of childhood cancers are paying off: a new study finds the 'first signal' of a decrease in cardiac toxicity.
  Medscape Medical News, January 16, 2020
• ASH 2019Lymphoma Now Curable, but Should Cost Be Considered? Scott Huntington, MD, MPH, discusses the cost of cancer drugs, and how prices have been increasing in recent decades, using the case of a real patient to illustrate his points.
  Medscape Medical News, January 07, 2020
• A Mixed Start for Immunotherapy in Childhood Cancers KEYNOTE-051 establishes a recommended pediatric dose for pembrolizumab and shows encouraging antitumor activity in one cancer type, but it was less effective in multiple other malignancies.
  Medscape Medical News, January 02, 2020
• Patients With Cancer at Increased Risk for Cardiovascular Death A population-based study found that cancer patients are at increased risk for death from cardiovascular disease compared to general population, highlighting the importance of cardio-oncology as a subspecialty.
  Medscape Medical News, November 26, 2019
• Newly Diagnosed Hodgkin Lymphoma Can Be Safely Managed During Pregnancy Hodgkin lymphoma diagnosed during pregnancy can be safely managed without interruption of pregnancy in most cases, according to new findings.
  Reuters Health Information, October 18, 2019
• Increased Cancer Incidence May Reflect 'Overdiagnosis' Epidemiologic signatures can provide insight into true cancer occurrence, overdiagnosis, and advances in treatment.
  Medscape Medical News, October 07, 2019
• Family Members at Higher Risk for Blood Cancers First-degree relatives of a patient with blood cancer are at an increased risk of also being diagnosed, suggesting a shared etiology across hematologic malignancies.
  Medscape Medical News, September 09, 2019
• GSK Builds Oncology Pipeline as Drug Shown to Help Myeloma Patients GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out of three previous treatment options, in a boost for the British drugmaker's cancer drug business.
  Reuters Health Information, August 23, 2019
• 'Impressive' Antitumor Effects An experimental agent had 'impressive' results in metastatic, pretreated cancers, especially breast cancer, in a phase 1/2 study.
  Medscape Medical News, July 02, 2019
• AstraZeneca-Daiichi Breast Cancer Treatment Shows Promise in Latest Study An experimental breast cancer drug being developed by British drugmaker AstraZeneca and Japan's Daiichi Sankyo's met its main goal in a mid-stage study, bolstering their position in a highly competitive oncology market.
  Reuters Health Information, May 08, 2019
• Cemiplimab and Talazoparib Head Toward Approval in the EU Both drugs have received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use, which is the first step in obtaining marketing approval in the European Union.
  International Approvals, April 29, 2019
• Consensus Guidelines Target Maintenance Therapies for Lymphomas After Autologous Transplant Maintenance therapy guidelines for lymphoma patients who have undergone autologous hematopoietic cell transplantation (HCT) were recently released by an expert panel from the American Society for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation.
  Reuters Health Information, March 07, 2019
• The 'London Patient' New HIV Remission Raises Hope HIV remission and cure are so rare as to be singularly notable. But is a new case of HIV remission replicable?
  Medscape Medical News, March 05, 2019
• Study of AYA-Cancer Survivors Can Guide Surveillance for New Primary Neoplasms A new study breaks down the excess risk of new primary malignancies in survivors of adolescent and young adult (AYA) cancers by the type of the first cancer, helping to inform surveillance efforts.
  Reuters Health Information, February 28, 2019
• Higher Risk of Lymphoma With Hidradenitis Suppurativa People with hidradenitis suppurativa face a lymphoma risk twice that of the general population, researchers report.
  Reuters Health Information, February 07, 2019
• Risk for Suicide Spikes After Cancer Diagnosis Two new studies show that after a cancer diagnosis, the risk for suicide increases significantly and may be as much as four times higher than in the general population.
  Medscape Medical News, January 17, 2019
• FDA Approves Pembrolizumab for Advanced Merkel Cell Carcinoma With this approval, patients with advanced/metastatic MCC will now have another treatment option.
  Medscape Medical News, December 20, 2018
• After 40 Years, 26% of Pediatric HL Survivors Have a Solid Tumor After pediatric Hodgkin lymphoma, the subsequent risk for a solid tumor goes on and on -- to 40 years and beyond.
  Medscape Medical News, December 18, 2018
• ASH 2018Four Cycles of CHOP Instead of Six for Favorable DLBCL Patients with favorable-prognosis DLBCL receiving four cycles of R-CHOP followed by two additional cycles of rituximab had outcomes similar to those in patients receiving six cycles.
  Medscape Medical News, December 02, 2018
• Alert Approval in 2 Weeks via FDA's New Oncology Drugs Review Approval of a new indication took only 2 weeks with the FDA's new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.
  FDA Approvals, November 16, 2018